Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Androgen Misuse and Abuse
David J. Handelsman
Endocrine Reviews (2021) Vol. 42, Iss. 4, pp. 457-501
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Cardiovascular Disease in Anabolic Androgenic Steroid Users
Josefine Windfeld‐Mathiasen, Ida M. Heerfordt, Kim Dalhoff, et al.
Circulation (2025)
Closed Access | Times Cited: 3
The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health
M. Alemany
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11952-11952
Open Access | Times Cited: 57
Injury and Poisoning Profile in Anabolic Steroid Users
Josefine Windfeld‐Mathiasen, Morten Tulstrup, Ida M. Heerfordt, et al.
Annals of Emergency Medicine (2025)
Open Access | Times Cited: 1
Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis
Giovanni Corona, Giulia Rastrelli, Clotilde Sparano, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 5, pp. 565-579
Closed Access | Times Cited: 6
Haematological actions of androgens
Annabelle M. Warren, Mathis Grossmann
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 36, Iss. 5, pp. 101653-101653
Closed Access | Times Cited: 27
Approach to the Patient: The Evaluation and Management of Men ≥50 Years With Low Serum Testosterone Concentration
Mathis Grossmann, Channa N. Jayasena, Bradley D. Anawalt
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 9, pp. e871-e884
Open Access | Times Cited: 11
Community pharmacy’s role in dispensing androgens and supporting harm reduction amid current policy dilemmas
Timothy Piatkowski, Lkhagvadulam Ayurzana, Michelle A. King, et al.
Substance Abuse Treatment Prevention and Policy (2025) Vol. 20, Iss. 1
Open Access
Testosterone deficiency and treatments: common misconceptions and practical guidance for patient care
M Khera, James M Hotaling, Martin Miner
Sexual Medicine Reviews (2025)
Open Access
Testosterone therapy and cardiovascular diseases
Antonio Cittadini, Andrea M. Isidori, Andrea Salzano
Cardiovascular Research (2021) Vol. 118, Iss. 9, pp. 2039-2057
Closed Access | Times Cited: 26
Psychiatric morbidity among men using anabolic steroids
Josefine Windfeld‐Mathiasen, Thea Christoffersen, Niels August Willer Strand, et al.
Depression and Anxiety (2022) Vol. 39, Iss. 12, pp. 805-812
Open Access | Times Cited: 18
Ageing male (part I): Pathophysiology and diagnosis of functional hypogonadism
Ilpo Huhtaniemi, Frederick C. W. Wu
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 36, Iss. 4, pp. 101622-101622
Closed Access | Times Cited: 17
Doping and sports endocrinology: anabolic-androgenic steroids
Juan Antonio García-Arnés, Natalia García‐Casares
Revista Clínica Española (English Edition) (2022) Vol. 222, Iss. 10, pp. 612-620
Open Access | Times Cited: 15
Doping with testosterone and androgenic/anabolic steroids: Impact on health, screening tools and medical care
Jacques Young
Annales d Endocrinologie (2023) Vol. 84, Iss. 3, pp. 401-405
Closed Access | Times Cited: 8
Serum Insulin-like Factor 3 Levels Are Reduced in Former Androgen Users, Suggesting Impaired Leydig Cell Capacity
Jon Rasmussen, Jakob Albrethsen, Mikkel Nicklas Frandsen, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 7, pp. e2664-e2672
Open Access | Times Cited: 17
Sexually transmitted doping: The impact of urine contamination of semen
David J. Handelsman, Feyrous Bacha, Marsha DeBono, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 9, pp. 1623-1628
Open Access | Times Cited: 11
Reliability of Drug History to Verify Androgen Abuse in Men
Nandini Shankara‐Narayana, Lance Brooker, Catrin Goebel, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 9, pp. e3790-e3796
Open Access | Times Cited: 11
Testosterone supplementation increases red blood cell susceptibility to oxidative stress, decreases membrane deformability, and decreases survival after cold storage and transfusion
Johnson Q. Tran, Rachael P. Jackman, Marcus O. Muench, et al.
Transfusion (2024) Vol. 64, Iss. 8, pp. 1469-1480
Closed Access | Times Cited: 2
Testosterone Usage Leading to Pulmonary Embolisms and Deep Vein Thrombosis: A Case Report and Review of the Literature
Sasmith Menakuru, Mona Atta, Vijaypal Dhillon, et al.
Hematology Reports (2023) Vol. 15, Iss. 2, pp. 290-297
Open Access | Times Cited: 6
Assessment of the inhibitory potential of anabolic steroids towards human AKR1D1 by computational methods and in vitro evaluation
Jacek Kędzierski, Julien Arthur Allard, Alex Odermatt, et al.
Toxicology Letters (2023) Vol. 384, pp. 1-13
Closed Access | Times Cited: 5
Association of urinary sex hormones with mood and behavior changes in a community adolescent cohort
Philip Hazell, Ben W.R. Balzer, Frances L. Garden, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0293040-e0293040
Open Access | Times Cited: 5
Interdisciplinary and Psychiatric Treatment of Anabolic Androgenic Steroids Users
Ingo Butzke, Samuel Iff, Michael Zitzmann, et al.
Praxis (2022) Vol. 111, Iss. 6, pp. e339-e344
Closed Access | Times Cited: 8
History of androgens and androgen action
David J. Handelsman
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 36, Iss. 4, pp. 101629-101629
Closed Access | Times Cited: 8
Predictors of Ongoing Androgen Abuse. A Prospective 2-year Follow up of 100 Male Androgen Abusers
Diederik L. Smit, Willem de Ronde
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 1, pp. e130-e136
Open Access | Times Cited: 4
Clomiphene citrate and optional human chorionic gonadotropin for treating male hypogonadism arising from long-term anabolic-androgenic steroid use—A pilot study
Hans Christian Bordado Henriksen, Anders Palmstrøm Jørgensen, Astrid Bjørnebekk, et al.
Performance Enhancement & Health (2024) Vol. 12, Iss. 3, pp. 100283-100283
Open Access | Times Cited: 1
Navigating non-medical androgen use: Towards a harm reduction paradigm
Diederik L. Smit, Tijs Verdegaal, Peter Bond, et al.
Performance Enhancement & Health (2024) Vol. 12, Iss. 4, pp. 100288-100288
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top